![]() |
|
|
Department of Biochemistry, Michigan State University, East Lansing, MI 48824
3To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: apoptosis immune response lymphopoiesis zinc deficiency
| Link between immune integrity and nutritional status |
|---|
|
|
|---|
For three decades, the hallmarks of malnutrition, especially of protein-calorie deficiencies (PCM) and zinc deficiency, were thymic atrophy and lymphopenia. The underlying mechanisms that create these two major changes in immune integrity are now documented and provide new insights into how nutritional deficiencies change the composition of the peripheral immune system and the regulation of hematopoiesis. The ability of zinc supplementation to offset the changes in immune function created by malnutrition and disease is also addressed.
| Prevalence of deficiencies in zinc among humans |
|---|
|
|
|---|
|
|
|
| Role of glucocorticoids in the alteration of immune defense for zinc and protein-calorie deficiencies |
|---|
|
|
|---|
| Impact of zinc deficiency on the immune system: Mouse models |
|---|
|
|
|---|
Nevertheless, the rapid impact of zinc deficiency on the murine immune
system was surprising. When body weight losses were 24 and 32%,
researchers observed 50 to 80% losses in thymus weight and 40
to 80% losses in antibody-mediated responses and so on
(Cook-Mills and Fraker 1993
, Fraker et al. 1993
). The losses in defense capacity closely correlated with
losses in absolute numbers of peripheral lymphocytes and splenocytes.
Thus, zinc-deficient mice with half the number of splenocytes
produced about half the number of antibody-producing cells as
normal mice (Cook-Mills and Fraker 1993
, Fraker et al. 1993
). Earlier studies indicated that on a per-cell
basis, the residual splenocytes of zinc-deficient mice produced
normal amounts of antibody and IL-2 and responded well to a battery of
mitogens (Cook-Mills and Fraker 1993
, Dowd et al. 1986
). More recent work using zinc-deficient weanling mice,
however, showed deficient production of IL-4, IL-5 and so on
(Shi et al. 1998
), although we noted no changes in the
phenotypic distribution (composition) of the various subsets of T and B
cells in the spleen (King and Fraker 1991
, Shi et al. 1998
). Collectively, these studies suggested that changes
in the production of lymphocytes (lymphopoiesis) might be a seminal
cause of lymphopenia that would in turn reduce cell- and
antibody-mediated responses. However, there has never been an
extensive study of the effects of a nutritional deficiency on
lymphopoiesis or myelopoiesis.
| Changes in lymphopoiesis created by zinc deficiency: emerging role for apoptosis |
|---|
|
|
|---|
However, no one had shown that the precursor B cells and other
progenitor cells in the marrow were susceptible to Gc-mediated
apoptosis because of the lack of available methodology. One could not
hope to purify sufficient precursor B cells (814%) (Hardy et al. 1991
) to evaluate for apoptosis using DNA gels
(semiquantitative) or morphology (laborious). Fortunately, the flow
cytometer can be used to readily quantify apoptotic cells in a
population (Telford et al. 1994
). By using multicolor
flow cytometry with fluorescently labeled antibodies specific for
progenitor and precursor B-cell markers along with a DNA dye, it
was shown that precursor B cells were as prone to Gc-induced
apoptosis as were thymocytes. Moreover, they responded intensely both
in vitro and in vivo to levels of steroid analogous to those found in
zinc deficiency and PCM (Garvy et al. 1993a
and
1993b
). It was subsequently shown that B cells from the
bone marrow of human subjects were equally sensitive to these steroids,
making the phenomenon relevant to human health (Lill-Elghanian,
D., Schwartz, K., King, L. and Fraher, P., unpublished data).
After having this methodology in hand, the next step was to demonstrate
that zinc deficiency rapidly depleted the B-cell compartment of the
marrow (Fraker et al. 1995
, King et al. 1995
). Recent work showed that zinc deficiency caused a
5070% decline in precursor B cells
(B220+CD43-IgM-),
with somewhat similar declines noted for immature B cells
(B220+IgM+IgD-)
(King et al. 1995
, Osati et al. 1998
).
Conversely, pro-B cells
(B220+CD43+6C3+)
exhibited no change in their distribution, gradually becoming a greater
proportion of the marrow as the compartment was depleted of precursor
and immature B cells (Osati et al. 1998
). Mature B cells
(IgM+IgD+) were also fairly
resistant to zinc deficiency. The explanation appears to be that
pro-B cells, which are just beginning gene rearrangements and are
not yet a problem or a threat, all express higher levels of bcl-2 than
precursor B cells and thus are more protected against apoptosis created
by zinc deficiency (Merino et al. 1994
). When expressed
at high levels, bcl-2 is a proto-oncogene that can block a variety
of death cues (Mignotte and Vayssier 1998
). Conversely,
because precursor B cells have a >90% chance of generating nonsense
clones and must be eliminated apoptotically (a few percent also became
anti-self clones), their expression of bcl-2 is quite low
(Merino et al. 1994
). Mature B cells, on the other hand,
which have made acceptable rearrangements, also express high levels of
bcl-2. Thus, the pattern of survival of B cells during zinc deficiency
paralleled bcl-2 expression and suggests that apoptosis is indeed a
component of the zinc deficiencyinduced depletion of the B-cell
compartment. Nevertheless, because apoptotic cells are quickly
phagocytosed, it has been difficult to directly prove that precursor T
and B cells are eliminated apoptotically in the zinc-deficient
mouse. Evidence provided by other laboratories indicate that zinc
deficiency causes apoptosis in embryos and enhances DNA strand breaks
in zinc-deficient infant rhesus monkeys (Olin et al. 1993
, Rogers et al. 1995
) and that calorie
restriction can also enhance apoptosis (Luan et al. 1995
). Apoptosis clearly plays a role in nutritional
deficiencies that must be better understood.
Thus, it is becoming evident that zinc deficiency has a substantial and rather specific impact on the lymphocytic branch of the immune system. The rapid depletion of the marrow and the thymus of precursor T and B cells as zinc deficiency advances reduces the ability of the immune system to replenish the peripheral blood and secondary immune tissues with adequate numbers of lymphocytes. Thus, a significant factor in the thymic atrophy and lymphopenia that accompany zinc deficiency is an alteration in the production of lymphocytes and loss of precursor cells via an apoptotic mechanism. Therefore, a reduced ability to replenish the lymphocyte population by the primary tissues of the immune system is a key player in the observed lymphopenia that reduces host defense. The rapid and dramatic decline in the proportion of precursor T and B cells in the marrow and thymus is another clear example of the tight link of segments of the immune system to zinc status.
| Potential resistance of myeloid cells |
|---|
|
|
|---|
50% increase in the Mac-1positive
population in the marrow of zinc-deficient mice that would include
cells of the myeloid series such as neutrophils,
macrophages-monocytes, basophils, eosinophils and others
(King et al. 1995The question then arose as to whether this change in the composition of the marrow was also apparent in the peripheral immune system. Preliminary studies revealed a rather remarkable twofold to threefold increase in the proportion of neutrophils in the blood of both moderate and severe zinc deficiency. Thus, there is a clear dichotomy in the effects of suboptimal dietary zinc on lymphopoiesis versus myelopoiesis that is rather striking and may represent a purposeful regulatory change in response to zinc deficiency.
A working hypothesis emerges from these findings. As zinc becomes
limiting, choices have to be made. Collectively, the marrow may be the
largest tissue of the body. Regardless, substantial amounts of zinc are
needed to produce billions of lymphocytes each day. They are the second
line of defense and often live and die without being gainfully used in
an immune response. This and the >90% error rate in their production
(Tarlinton 1994
) make them nutritionally expensive to
maintain. As zinc deficiency advances, it seems that lymphopoiesis is
put on the chopping block to be reduced in part by Gc-mediated
apoptotic mechanisms. Conversely, myelopoiesis survives at least for a
time, perhaps to provide some basic or minimal immune protection.
| Role of zinc status in cell survival and death |
|---|
|
|
|---|
Our interest in the above information stems from our observations and
those of others that zinc itself can modulate apoptosis (Fraker and Telford 1997
, McCabe et al. 1993
,
Telford and Fraker 1995
, 1998
,
Zalewski and Forbes 1993
). It is evident that apoptosis
plays key roles in immune integrity via the elimination of
anti-self and nonsense clones and the successful killing of
aberrant target cells by cytolytic T cells (Ucker 1997
).
The number of diseases in which apoptosis plays a role grows yearly,
e.g., cancer, AIDS, ischemia, autoimmune disease, stroke and
neurodegenerative diseases, especially Parkinsons and Alzheimers
diseases (Ucker 1997
, Webb et al. 1997
).
Thus, it is important to identify substances that can modulate
apoptosis, and zinc may be such a candidate. Moreover, it is our belief
that apoptosis plays important roles in the changes in embryogenesis,
reproduction capacity, growth and immune integrity brought about by
nutritional deficiencies; these must be given greater consideration,
and a better understanding of the interplay between zinc and apoptosis
is critical.
Apoptosis begins with a death signal, which could be a change in the
activity of an enzyme like protein kinase C or binding of Gc to the Gc
receptor with translocation to the nucleus and the induction of death
genes (Schwartzman and Cidlowski 1993
) (Fig. 1
). In the case of the pathway used by steroids and
-irradiation (and,
we believe, zinc), the expression of bcl-2/bax is a checkpoint in the
pathway (Chao and Korsmeyer 1998
, Schwartzman and Cidlowski 1993
, Ucker 1997
, Webb et al. 1997
). As discussed earlier, high expression of bcl-2 generally
provides enhanced protection, whereas low levels lead to cell death
(Chao and Korsmeyer 1998
, Ucker 1997
).
bcl-2 is a family of proto-oncogenes found primarily in
hematopoietic cells whose exact function is not yet known (Chao and Korsmeyer 1998
, Schwartzman and Cidlowski 1993
). There is growing evidence that it is associated with
pores in the mitochondrial membrane. When highly expressed, bcl-2 may
prevent the opening of the mitochondria pores and the release of
cytochrome c into the cytoplasm, which activates proteases
or caspases, an intermediary event in the death cascade
(Mignotte and Vayssier 1998
). There also are potential
increases in the generation of reactive oxygen species. An endonuclease
is activated that cleaves the DNA into 180-bp fragments, destroying the
genome of the cell (Cohen and Duke 1984
,
Schwartzman and Cidlowski 1993
). Dramatic changes in the
morphology of the cell also occur due to condensation of the
cytoskeleton and inversion of the membrane lipids (Cohen and Duke 1992
, Schwartzman and Cidlowski 1993
). As
will be discussed, zinc can also induce apoptosis (Fraker and Telford 1997
, Telford and Fraker 1995
,
1998
), and it will be helpful to know whether it follows
this classic pathway of death.
|
| Ability of zinc to induce apoptosis |
|---|
|
|
|---|
Future studies of modulation of cell death by zinc could lead to the identification of important new roles for zinc. Clearly, small changes in cellular zinc may play a role in the loss of precursor cells in the immune system. Perhaps suboptimal zinc and the chronic production of Gc act in synergy to heighten levels of apoptosis in precursor T and B cells as zinc deficiency advances, thereby causing lymphopenia, as discussed earlier. Likewise, cells under stress or cells in a dysregulated or an aging system may experience fluxes in zinc that might promote apoptosis.
| Impact of zinc supplementation on immune integrity |
|---|
|
|
|---|
|
| Important areas of need |
|---|
|
|
|---|
With regard to the interactions between the immune system and nutrients such as zinc, the surface has been barely scratched. Most of the immunological studies performed to date have centered around the peripheral immune system. We know little about the effect of zinc deficiency and the use of zinc supplements on the mucosal immune system. Changes in gut immunology created by malnutrition no doubt contributed to the ongoing high mortality rates of children in developing nations created by infections with Escherichia coli, Salmonella, dysentery, cholera and others that create havoc in the intestine. Also, few details are known about the impact of nutritional status on pulmonary immunology and the resulting incidence of pneumonia, bronchitis, allergy or tuberculosis. We know little about the relationship of nutritional status to the acute phase response regardless of whether one considers its protective or inflammatory mode. How does suboptimal nutriture affect the fetal-neonatal immune system, and how readily is repair of immune integrity manifested when dietary status is improved? Is there a subset of elderly persons who would truly benefit from zinc supplementation, and how do we identify them? We also know little about the impact of marginal zinc status on viral or cancer defense systems. Supplementation with zinc might reduce the impact of these diseases and conditions.
Clearly, the mouse model shows that zinc is essential to lymphopoiesis and that when zinc is suboptimal, there is significant depletion of precursor lymphoid cells from the primary tissues of the immune system. The dramatic effect of zinc deficiency on marrow function is another indication of the dynamic link between immune status and zinc status. This is no doubt an underlying cause of the lymphopenia, thymic atrophy and reduced cell- and antibody-mediated responses associated with zinc deficiency. This could well be the case for PCM and other nutritional deficits and thus provides a path for others. Moreover, subsets of developing B cells in the marrow varied in sensitivity to zinc deficiency, with those expressing high levels of bcl-2 being the most resistant. This, along with other data, strongly suggests that apoptosis is one of the seminal causes of these losses. No doubt apoptosis plays a role in many of the physiological changes created by zinc deficiency. Conversely, myeloid cells in the marrow, in particular neutrophils and monocytes, exhibited substantial resistance to zinc deficiency. This is an incredible dichotomy in the effects of zinc deficiency on regulation within the marrow and is the first study to demonstrate the impact of a nutritional deficiency on marrow function. Understanding the nature of the changes in marrow function created by zinc deficiency opens the way for therapeutic intervention.
Studies also now exist that demonstrate that changes in zinc status can modulate apoptosis, providing new roles for zinc. Fluxes of zinc in the cell; synergy between zinc and Gc; and dysregulation of cellular zinc during stress, aging, autoimmune disease, ischemia, Alzheimers disease and others may therefore affect cell survival. Demonstration of the ability of zinc to modulate cell survival would, we hope, prompt other nutritionists to also examine the role apoptosis may play in altered growth, development, reproduction and senescence during deficiency states.
| FOOTNOTES |
|---|
2 Supported in part by National Institutes of Health Grant DK52289. ![]()
4 Abbreviations used: AIDS, acquired immune deficiency syndrome; Dex, dexamethasone; DTH, delayed type hypersensitivity; Gc, glucocorticoid; IL-2, interleukin-2; NK, natural killer; PCM, protein-calorie deficiency ![]()
| REFERENCES |
|---|
|
|
|---|
1. Allen J. I., Perri R. T., McClain C. J., Kay N. E. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J. Lab. Clin. Med. 1983;102:577-589[Medline]
2. Alleyne G. A., Young V. H. Adrenocortical function in children with severe protein-calorie malnutrition. Clin. Sci. 1967;33:189-200[Medline]
3. Anonymous Zinc therapy of depressed cellular immunity in acrodermatitis enteropathica. Nutr. Rev. 1981;39:168-170[Medline]
4. Baum M., Shor-Posner G., Lu Y. Micronutrients and HIV-1 disease progression. AIDS 1995;9:1051-1056[Medline]
5. Becker D. J. The endocrine responses to protein calorie malnutrition. Annu. Rev. Nutr. 1983;3:187-212[Medline]
6. Bettger W., Odell B. Physiological roles of zinc in the plasma membrane of mammalian cells. J. Nutr. Biochem. 1993;4:194-207
7.
Bray T., Levy M., Sikorski B., Bray T. Selective elevation of glutathionine levels in target tissues with OTC protects against hyperoxia-induced lung damage in protein-energy malnourished rats: implications for a new treatment strategy. J. Nutr. 1998;128:671-676
8.
Castillo-Duran C., Heresi G., Fisberg M., Uauy R. Controlled trial of zinc supplementation during recovery from malnutrition: effects on growth and immune function. Am. J. Clin. Nutr. 1987;45:602-608
9. Chandra R., Newberne P. Nutrition, Immunity and Infection 1977 Plenum Press New York, NY.
10. Chao D., Korsmeyer S. BCL-2 family: regulation of cell death. Annu. Rev. Immunol. 1998;16:395-419[Medline]
11. Chester J. Zinc. Odell B. Sunde R. eds. Handbook of Nutritionally Essential Mineral Elements 1997:185-230 Marcel Dekker New York, NY.
12. Chester J., Petrie L., Lipson K. Two zinc dependent steps during G1 to S phase transition. J. Cell Physiol. 1993;155:445-451[Medline]
13. Cohen J., Duke R. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 1992;10:267-304[Medline]
14. Cohen J. J., Duke R. C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 1984;132:38-42[Abstract]
15. Cook-Mills J., Fraker P. J. Functional capacity of residual lymphocytes from zinc-deficient adult mice. Br. J. Nutr. 1993;69:835-848[Medline]
16. DePasquale-Jardieu P., Fraker P. J. The role of corticosterone in the loss in immune function in the zinc-deficient A/J mouse. J. Nutr. 1979;109:1847-1855
17. DePasquale-Jardieu P., Fraker P. J. Further characterization of the role of corticosterone in the loss of humoral immunity in zinc-deficient A/J mice as determined by adrenalectomy. J. Immunol. 1980;124:2650-2655[Medline]
18. Dexter T., Allen T., Lajtha L. Conditions controlling the proliferation of hemopoietic stem cells in vitro. J. Cell Physiol. 1977;91:335-344[Medline]
19. Dowd P. S., Kelher J., Guillou P. J. T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br. J. Nutr. 1986;55:59-69[Medline]
20. Endre L., Beck F., Prasad A. The role of zinc in human health. J. Trace Elem. Exp. Med. 1990;3:337
21.
Fernandes G., Nair N., Onoe K., Tanaka T., Floyd R., Good R. Impairment of cell mediated immunity function in dietary zinc deficiency in mice. Proc. Natl. Acad. Sci. U.S.A. 1979;76:457-461
22. Fraker P., King L. Changes in regulation of lymphopoiesis and myelopoiesis in the zinc-deficient mouse. Nutr. Rev. 1998;56:565-569
23. Fraker P., Osati-Ashtiani F., Wagner M., King L. L. Possible roles for glucocorticoids and apoptosis in the suppression of lymphopoiesis during zinc deficiency. J. Am. Coll. Nutr. 1995;14:11-17[Abstract]
24. Fraker P., Telford W. A reappraisal of the role of zinc in the life and death decisions of life. Proc. Soc. Exp. Med. 1997;215:229-236
25. Fraker P. J., Caruso R., Kierszenbaum F. Alteration of the immune and nutritional status of mice by synergy between zinc deficiency and infection with Trypanosoma cruzi. J. Nutr. 1982;112:1224-1229
26. Fraker P. J., King L., Garvy B., Medina C. Immunopathology of zinc deficiency: a role for apoptosis. Klurfeld D. eds. Human Nutrition: A Comprehensive Treatise 1993;vol. 8:267-283 Plenum Press New York, NY.
27. Garvy B., King L., Telford W., Morford L., Fraker P. J. Chronic levels of corticosterone reduces the number of cycling cells of the B-lineage in murine bone marrow and induces apoptosis. Immunology 1993a;80:587-592[Medline]
28. Garvy B., Telford W., King L., Fraker P. J. Glucocorticoids and irradiation induced apoptosis in normal murine bone marrow B-lineage lymphocytes as determined by flow cytometry. Immunology 1993b;79:270-277[Medline]
29. Golden M., Golden B., Harland P., Jackson A. Zinc and immunocompetence in protein energy malnutrition. Lancet 1978;1:1226-1228[Medline]
30.
Hallolloran T. Transition metals in control of gene expression. Science (Washington DC) 1993;261:715-724
31.
Hardy R. R., Carmack C.E., Shinton S. A., Kemp J. D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 1991;173:1213-1225
32. Hill A., Naama H., Gallagher H., Shoa J., Calvano S., Daly J. Glucocorticoid mediated macrophage dysfunction in protein calorie malnutrition. Surgery 1995;118:130-137[Medline]
33. Janeway, C. (1998) Reducing animal care costs: value of mouse model. Presidential Speech to AAI. See American Association of Immunologists Website: www.science.com/aai/.
34. Kaplan J., Hess J. W., Prasad A. S. Impairment of immune function in the elderly: association with mild zinc deficiency. Essential and Toxic Trace Elements in Human Health and Disease 1988:309-317 Alan R. Liss New York, NY.
35. Keen C., Gershwin M. Zinc deficiency and immune function. Annu. Rev. Nutr. 1990;10:415-431[Medline]
36. King L. E., Fraker P. J. Flow cytometric analysis of the phenotypic distribution of splenic lymphocytes in zinc-deficient adult mouse. J. Nutr. 1991;121:1433-1438
37. King L. E., Osati-Ashtiani F., Fraker P. Depletion of cells of the B-lineage in the bone marrow of zinc-deficient mouse. Immunology 1995;85:69-73[Medline]
38. Kuvibidila S., Yu L., Ode D., Warrier R. P. The immune response in protein-energy malnutrition and single nutrient deficiencies. Klurfeld D. M. eds. Human Nutrition: A Comprehensive Treatise 1993;vol. 8:121-157 Plenum Press New York, NY.
39.
Liles W., Dale D., Klebanoff S. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181-3188
40. Luan X., Zhao W., Chandrasekar B., Fernandes G. Caloric restriction of MRL/lpr that are prone to autoimmunity enhanced Dex induced apoptosis. Immunol. Lett. 1995;47:181-186[Medline]
41. Luecke R. W., Simonel C. E., Fraker P. J. The effect of restricted dietary intake on the antibody-mediated response of the zinc-deficient A/J mouse. J. Nutr. 1978;108:881-887
42.
Maret W., Vallee B. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. U.S.A. 1998;95:3478-3482
43. McCabe M. J., Jr, Jiang S. A., Orrenius S. Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab. Invest. 1993;69:101-110[Medline]
44. Meagher L., Cousin J., Seckl J., Hoslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophil and eosinophilic granulocytes. J. Immunol. 1996;156:4422-4428[Abstract]
45. Merino R., Ding L., Veis D., Korsmeyer S., Nunez G. Development regulation of the Bcl-2 protein and susceptibility to cell death in B-lymphocytes. EMBO J 1994;13:683-691[Medline]
46. Mignotte B., Vayssier J. Mitochondria and apoptosis. Eur. J. Biochem. 1998;252:1-15[Medline]
47. Olin K., Shingenaga M., Ames B., Golub M., Gershwin M., Hendrickx A., Keen C. Maternal dietary zinc influences DNA strand break and 8-hydroxy-2-deoxyguanosine levels in infant rhesus monkey liver. Proc. Soc. Exp. Biol. Med. 1993;203:461-466[Abstract]
48. Osati F., King L., Fraker P. Variance in the resistance of murine early B cells to a deficiency in zinc. Immunology 1998;94:94-100[Medline]
49.
Palmiter R., Cole T., Quaife C., Findley S. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc. Natl. Acad. Sci. U.S.A. 1996;93:14934-14939
50.
Pena M., Koch K., Thiele D. Dynamic regulation of copper uptake and detoxification genes in Saccharomyces cerevisiae. Mol. Cell Biol. 1998;18:2514-2523
51. Rogers J., Taubeneck M., Daston G., Sulik K., Zucher R., Elstein K., Janowski M., Keen C. Zinc deficiency causes apoptosis but not cell cycle alterations in organogenesis-stage rate embryos: effect of varying duration of deficiency. Teratology 1995;52:149-159[Medline]
52.
Sazawal S., Black R. E., Jalla S., Mazumdar S., Sinha A., Bhan M. K. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics 1998;102:1-4
53. Schwartzman R., Cidlowski J. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 1993;14:133-151[Medline]
54.
Shi H., Scott M., Stevenson M., Koski K. Energy restriction and zinc deficiency repair the function of murine T cells and antigen-presenting cells during gastrointestinal nematode infection. J. Nutr. 1998;128:20-27
55. Smith H. F., Latham M. C., Azaburke J. A., Butler W. R., Phillips L. S., Pond S. G., Enwonwu C. O. Blood plasma levels of cortisol, insulin, growth hormone, and somatomedin in children with marasmus, kwashiorkor and intermediate forms of protein-energy malnutrition. Proc. Soc. Exp. Biol. Med. 1981;167:607-611[Medline]
56. Tarlinton D. B cell differentiation in the bone marrow and the periphery. Immunol. Rev. 1994;137:203[Medline]
57.
Telford W., Fraker P. Preferential induction of apoptosis in mouse CD4+CD8+
ßTCRloCD3
lo thymocytes by zinc. J. Cell Physiol. 1995;164:259-270